Testosterone cypionate trials for Metastatic Castration-resistant Prostate Cancer

All Testosterone cypionate trials · All Metastatic Castration-resistant Prostate Cancer trials

Phase breakdown

Recruiting trials studying Testosterone cypionate for Metastatic Castration-resistant Prostate Cancer

• Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
  NCT06100705 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
  NCT07142551 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• The COSMYC Trial (COmbined Suppression of MYC)
  NCT06922318 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Testosterone cypionate for Metastatic Castration-resistant Prostate Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.